80 related articles for article (PubMed ID: 3421576)
1. Inhibition of human platelet function in vivo with a monoclonal antibody. With observations on the newly dead as experimental subjects.
Coller BS; Scudder LE; Berger HJ; Iuliucci JD
Ann Intern Med; 1988 Oct; 109(8):635-8. PubMed ID: 3421576
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.
Gold HK; Gimple LW; Yasuda T; Leinbach RC; Werner W; Holt R; Jordan R; Berger H; Collen D; Coller BS
J Clin Invest; 1990 Aug; 86(2):651-9. PubMed ID: 2384607
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet monoclonal F(ab')2 antibody directed against the platelet GPIIb/IIIa receptor complex prevents coronary artery thrombosis in the canine heart.
Mickelson JK; Simpson PJ; Lucchesi BR
J Mol Cell Cardiol; 1989 Apr; 21(4):393-405. PubMed ID: 2746660
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric observations on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb-IIIa.
Christopoulos C; Mackie I; Lahiri A; Machin S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):729-37. PubMed ID: 8292722
[TBL] [Abstract][Full Text] [Related]
5. Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors.
Kleiman NS; Raizner AE; Jordan R; Wang AL; Norton D; Mace KF; Joshi A; Coller BS; Weisman HF
J Am Coll Cardiol; 1995 Dec; 26(7):1665-71. PubMed ID: 7594101
[TBL] [Abstract][Full Text] [Related]
6. Conjugation and evaluation of 7E3 x P4B6, a chemically cross-linked bispecific F(ab')2 antibody which inhibits platelet aggregation and localizes tissue plasminogen activator to the platelet surface.
Neblock DS; Chang CH; Mascelli MA; Fleek M; Stumpo L; Cullen MM; Daddona PE
Bioconjug Chem; 1992; 3(2):126-31. PubMed ID: 1515466
[TBL] [Abstract][Full Text] [Related]
7. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets.
Wagner CL; Mascelli MA; Neblock DS; Weisman HF; Coller BS; Jordan RE
Blood; 1996 Aug; 88(3):907-14. PubMed ID: 8704248
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model.
Coller BS; Folts JD; Scudder LE; Smith SR
Blood; 1986 Sep; 68(3):783-6. PubMed ID: 2943335
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of thrombocyte aggregation by F(ab')2-fragments of monoclonal antibodies FraMon (CRC64) to glycoproteins IIb-IIIa].
Mazurov AV; Pevzner DV; Khaspekova SG; Dudnik OA; Byzova TV; Vlasik TN; Bakharev VN; Pistsov MIu; Staroverov II; Ruda MIa
Ter Arkh; 2001; 73(9):66-73. PubMed ID: 11642086
[TBL] [Abstract][Full Text] [Related]
10. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
11. Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. I. Adjunctive therapy with monoclonal antibody 7E3 F(ab')2 fragment.
Rote WE; Mu DX; Bates ER; Nedelman MA; Lucchesi BR
J Cardiovasc Pharmacol; 1994 Feb; 23(2):194-202. PubMed ID: 7511747
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of dog platelet function by in vivo infusion of F(ab')2 fragments of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor.
Coller BS; Scudder LE
Blood; 1985 Dec; 66(6):1456-9. PubMed ID: 2998514
[TBL] [Abstract][Full Text] [Related]
13. Time course of the effects of a single bolus injection of F(ab')2 fragments of the antiplatelet GPIIb/IIIa antibody 7E3 on arterial eversion graft occlusion, platelet aggregation, and bleeding time in dogs.
Kiss RG; Lu HR; Roskams T; Jang IK; Plow EF; Gold HK; Collen D
Arterioscler Thromb; 1994 Mar; 14(3):367-74. PubMed ID: 8123640
[TBL] [Abstract][Full Text] [Related]
14. 7E3 F(ab')2, an effective antagonist of rat alphaIIbbeta3 and alphavbeta3, blocks in vivo thrombus formation and in vitro angiogenesis.
Sassoli PM; Emmell EL; Tam SH; Trikha M; Zhou Z; Jordan RE; Nakada MT
Thromb Haemost; 2001 May; 85(5):896-902. PubMed ID: 11372685
[TBL] [Abstract][Full Text] [Related]
15. [Identification of human platelet specific functional antibody and its fragments].
Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of platelet aggregation with monoclonal antibodies to the glycoprotein IIb-IIIa complex].
Byzova TV; Vlasik TN; Mazurov AV
Biull Eksp Biol Med; 1994 Oct; 118(10):402-5. PubMed ID: 7865820
[No Abstract] [Full Text] [Related]
17. Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty.
Mazurov AV; Pevzner DV; Antonova OA; Byzova TV; Khaspekova SG; Semenov AV; Vlasik TN; Samko AN; Staroverov II; Ruda MY
Platelets; 2002 Dec; 13(8):465-77. PubMed ID: 12487780
[TBL] [Abstract][Full Text] [Related]
18. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
Schneider DJ; Taatjes DJ; Sobel BE
Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364
[TBL] [Abstract][Full Text] [Related]
20. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation.
Mojica Muñoz AK; Jamasbi J; Uhland K; Degen H; Münch G; Ungerer M; Brandl R; Megens R; Weber C; Lorenz R; Siess W
Thromb Haemost; 2017 Aug; 117(8):1651-1659. PubMed ID: 28569920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
